Salvatore Calabrese - Net Worth and Insider Trading
Salvatore Calabrese Net Worth
The estimated net worth of Salvatore Calabrese is at least $0 dollars as of 2024-05-24. Salvatore Calabrese is the CHIEF FINANCIAL OFFICER of Gain Therapeutics Inc and owns about 0 shares of Gain Therapeutics Inc (GANX) stock worth over $0. Details can be seen in Salvatore Calabrese's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Salvatore Calabrese has not made any transactions after 2022-05-19 and currently still holds the listed stock(s).
Transaction Summary of Salvatore Calabrese
Salvatore Calabrese Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Salvatore Calabrese owns 1 companies in total, including Gain Therapeutics Inc (GANX) .
Click here to see the complete history of Salvatore Calabrese’s form 4 insider trades.
Insider Ownership Summary of Salvatore Calabrese
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GANX | Gain Therapeutics Inc | 2022-05-19 | Chief Financial Officer |
Salvatore Calabrese Latest Holdings Summary
Salvatore Calabrese currently owns a total of 1 stock. Salvatore Calabrese owns 0 shares of Gain Therapeutics Inc (GANX) as of May 19, 2022, with a value of $0.
Latest Holdings of Salvatore Calabrese
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GANX | Gain Therapeutics Inc | 2022-05-19 | 0 | 2.45 | 0 |
Holding Weightings of Salvatore Calabrese
Salvatore Calabrese Form 4 Trading Tracker
According to the SEC Form 4 filings, Salvatore Calabrese has made a total of 2 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Gain Therapeutics Inc is the acquisition of 3,000 shares on May 19, 2022, which cost Salvatore Calabrese around $24 Million.
Insider Trading History of Salvatore Calabrese
- 1
Salvatore Calabrese Trading Performance
GuruFocus tracks the stock performance after each of Salvatore Calabrese's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Salvatore Calabrese is 35.56%. GuruFocus also compares Salvatore Calabrese's trading performance to market benchmark return within the same time period. The performance of stocks bought by Salvatore Calabrese within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Salvatore Calabrese's insider trading performs compared to the benchmark.
Performance of Salvatore Calabrese
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.22 | | | | | |
| Relative Return to S&P 500(%) | 28.01 | | | | | |
Salvatore Calabrese Ownership Network
Salvatore Calabrese Owned Company Details
What does Gain Therapeutics Inc do?
Who are the key executives at Gain Therapeutics Inc?
Salvatore Calabrese is the Chief Financial Officer of Gain Therapeutics Inc. Other key executives at Gain Therapeutics Inc include Chief Operating Officer Matthias Alder , Chief Financial Officer Charles Evan Ballantyne , and Principal Accounting Officer Gianluca Fuggetta .
Gain Therapeutics Inc (GANX) Insider Trades Summary
Over the past 18 months, Salvatore Calabrese made no insider transaction in Gain Therapeutics Inc (GANX). Other recent insider transactions involving Gain Therapeutics Inc (GANX) include a net sale of 2,026 shares made by Matthias Alder , and a net purchase of 30,000 shares made by Jeffrey Scott Riley .
In summary, during the past 3 months, insiders sold 0 shares of Gain Therapeutics Inc (GANX) in total and bought 30,000 shares, with a net purchase of 30,000 shares. During the past 18 months, 2,026 shares of Gain Therapeutics Inc (GANX) were sold and 30,000 shares were bought by its insiders, resulting in a net purchase of 27,974 shares.
Gain Therapeutics Inc (GANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gain Therapeutics Inc Insider Transactions
Salvatore Calabrese Mailing Address
Above is the net worth, insider trading, and ownership report for Salvatore Calabrese. You might contact Salvatore Calabrese via mailing address: C/o Gain Therapeutics, Inc., 4800 Hampden Lane, Suite 200, Bethesda Md 20814.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
